Here is the latest stock price and chart of MANGALAM DRUGS. For more details, see the MANGALAM DRUGS company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Live BSE Quotes | Nov 21, 2024 (Close) | ||
---|---|---|---|
Price (Rs)104.80 | Open (Rs) 106.00 | High (Rs) 106.05 | Low (Rs) 103.90 |
% Change-1.41 | Volume 2,698 | Value (Rs) 282,284 | 52-Week H/L 144.65 / 85.16 |
Live NSE Quotes | Nov 21, 2024 (Close) | ||
---|---|---|---|
Price (Rs)103.92 | Open (Rs) 105.06 | High (Rs) 106.13 | Low (Rs) 103.66 |
% Change-2.30 | Volume 24,565 | Value (Rs) 2,564,214 | 52-Week H/L 144.99 / 90.80 |
Change | |||||
---|---|---|---|---|---|
1 Day -1.41% | 1 Month -9.81% | 3 Months -16.26% | 1 Year 7.65% | 5 Years (CAGR)* 27.67% | 10 Years (CAGR)* 16.50% |
* Compound Annual Growth Rate
Valuation | ||||
---|---|---|---|---|
EPS (Rs)* 1.99 | P/E Ratio (x) 52.59 | Market Cap (Rs m) 1,658.80 | P/BV (x) 1.22 | Dividend Yield (%) 0.00 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX
|
||||||
PERIOD |
MANGALAM DRUGS last traded price was down 1.4% to Rs 104.8 on the BSE. On the NSE, MANGALAM DRUGS last traded price was down 2.3% to Rs 103.9. The total volume of shares traded was 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 0.1%. And the benchmark S&P BSE SENSEX was at 77,155.8 (down 0.5%).
Over the last 30 days, the MANGALAM DRUGS share price is down 9.8%. And over the last one year, MANGALAM DRUGS share price is up 8.9%.
The current market capitalisation of MANGALAM DRUGS stands at Rs 1,658.80 m. For more information, check out the list of top 100 companies in India in terms of market cap.
As of September 2024, promoter pledging in MANGALAM DRUGS stands at 10.26%. To know more, check out the latest shareholding pattern of MANGALAM DRUGS.
The last traded price of MANGALAM DRUGS was Rs 104.8 on the BSE, down 1.4% over the previous close. On the NSE, MANGALAM DRUGS last traded price was down 2.3% at Rs 103.9.
The current market capitalisation of MANGALAM DRUGS stands at Rs 1,659 m. For more information, check out the list of top 100 companies in India in terms of market cap.
MANGALAM DRUGS had an EPS of Rs 2.0 in the latest financial year. In the most recent quarter, the company declared an EPS of Rs 1.7.
For the financial year 2024, MANGALAM DRUGS declared dividend amounting to Rs 0.0 per share. At the current price of Rs 104.8, this results in a dividend yield of 0.0%.
Based on marketcap, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks ranked by marketcap here.
Also, here's one of our more popular screens related to marketcap: India's Biggest Companies by Marketcap.
Based on sales, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
Curious to know which Indian companies are growing their sales at a faster rate than their peers? Check out India's Fastest Growing Companies by Sales.
Based on net profit, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
In case you are wondering which company logs in the biggest net profit margin in India, check this out: High Profit Margin Companies in India.
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.